His general practitioner had referred him for a sleep study (mild sleep apnea, “not severe enough for CPAP”), and his neurologist had tried him on preventive migraine medication that hadn’t helped, because his headaches weren’t migraine. Sam was forty-two before anyone thought to look inside his nose with an endoscope. The ENT who examined him spent about ninety seconds before saying: “Your septum is significantly deviated to the left, and it’s completely blocking your left nasal valve.
This has almost certainly been causing your headaches, your snoring, and a major contribution to your sleep apnea. We can fix this.” Sam stared at him. “Why didn’t anyone tell me this twenty years ago?”
Deviated nasal septum is one of medicine’s most common under-considered diagnoses. It affects a majority of the adult population to some degree — studies using CT and endoscopic examination find significant deviation in 70 to 80 percent of adults — making “deviated septum” more rule than exception.
The clinical significance varies enormously: mild deviations that don’t significantly obstruct airflow are incidental findings of no consequence; moderate to severe deviations that significantly narrow or obstruct one nasal airway cause a cascade of functional consequences extending far beyond simple nasal congestion.
This article covers the complete clinical picture of deviated nasal septum: the anatomy, the causes, the functional consequences, the evaluation, and the treatment — with particular attention to the interaction between septal deviation and related conditions including nasal valve dysfunction, sleep-disordered breathing, and headache — plus the septoplasty procedure, its outcomes, and its limitations.
Septal Anatomy and What Deviation Actually Means
The nasal septum divides the nasal cavity into right and left chambers. It has both cartilaginous and bony components: the anterior portion is the quadrilateral cartilage (also called the septal cartilage), providing structural support for the external nose and the anterior nasal airway; the posterior septum is formed by the perpendicular plate of the ethmoid bone (upper) and the vomer (lower), both rigid bony structures.
The septum is lined by mucosa on both sides and supported in a groove in the maxillary crest at its inferior border, articulating with the hard palate.
Septal deviation describes displacement of the septum away from the midline — toward one side of the nasal cavity, reducing the space on the side toward which it deviates and often widening the contralateral (opposite) side.
The deviation can involve any part of the septum: isolated cartilaginous deviation (affecting the anterior airway, often creating the visible external nose deviation), posterior bony deviation (affecting the internal airway primarily, not visible externally), C-shaped deviation (curving toward one side for the entire septum length), or S-shaped deviation (curving toward one side anteriorly and the other posteriorly — sometimes producing bilateral obstruction with symptoms on both sides despite an S-configuration that appears more “balanced”).
Spurs — sharp bony projections at the junction of the septal cartilage and the vomer, typically at the floor of the nose — are a specific form of septal abnormality causing localized airway obstruction and, when large enough to contact the inferior turbinate or lateral nasal wall, reflex headache through contact pressure on the mucosal surface.
The nasal septum’s sensory innervation includes branches of the ophthalmic and maxillary divisions of the trigeminal nerve, and mucosal contact between deviated septum and the turbinates or lateral wall can trigger trigeminal nerve-mediated headache — sometimes called “rhinogenic headache” or “contact point headache” — that may get misdiagnosed as migraine or tension headache for years.
The inferior turbinate deserves particular attention here because the two structures are dynamically related. The turbinates are shelf-like projections from the lateral nasal wall covered by thick, highly vascular mucosa that physiologically expands and contracts to regulate airflow. The inferior turbinate on the side opposite a significant septal deviation often becomes hypertrophic — compensatory enlargement partially filling the wider contralateral nasal chamber.
This compensatory turbinate hypertrophy is physiologically adaptive (maintaining some degree of bilateral airflow regulation) but becomes clinically important when surgical correction of the septum is planned, because the hypertrophied turbinate may obstruct the airway on what was previously the “better” side once the septum is straightened, if the turbinate isn’t simultaneously addressed.
Causes: Trauma, Development, and Birth
Septal deviation arises from two main categories of cause: developmental and traumatic. The proportions of each in any given population depend on the age of the group studied and the history of exposure to nasal trauma — but most significant deviations in adults have both developmental and traumatic contributions.
Developmental deviation begins in utero — birth trauma is a significant and underappreciated cause. The nasal septum is exposed to deforming forces during passage through the birth canal, particularly during vertex presentations (head-first deliveries) and especially in prolonged or difficult labors. Studies using nasal endoscopy in newborns have found significant septal deviations in 20 to 40 percent of neonates, with rates substantially higher after difficult deliveries and in larger babies.
The elasticity of neonatal cartilage lets the deformed septum appear relatively normal externally, but the structural deviation may persist and become more pronounced as the cartilage matures and the facial skeleton grows.
The nasal cartilage has intrinsic growth patterns developing through childhood and adolescence, driven by the differential growth rates of the nasal cartilage versus the surrounding bony skeleton. Asymmetric growth between the septal cartilage and the maxillary crest can produce deviation even without trauma. The adolescent growth spurt — during which the nose grows significantly — can convert what was a mild developmental deviation into a clinically significant one.
Many patients who develop symptoms in their teens and twenties have predominantly developmental deviation without a specific remembered traumatic event.
Traumatic deviation is most commonly from nasal fractures — direct blows to the nose from sports injuries, assaults, motor vehicle accidents, and falls. Nasal fractures are among the most common facial injuries, and incomplete or improperly reduced nasal fractures are a major cause of post-traumatic septal deviation.
The management of acute nasal fracture is time-sensitive: reduction (manipulating the fractured bones back to midline position) is most effective within the first 10 to 14 days, before the healing process locks the bones in their displaced position. After this window, correction of residual deviation requires formal septorhinoplasty rather than simple reduction under local anesthesia.
Functional Consequences: More Than Just Congestion
The clinical consequences of significant septal deviation extend well beyond simple unilateral nasal congestion — the symptom most people (and many clinicians) associate with the condition. Understanding the full functional impact explains why many patients with documented deviation don’t connect their symptoms to the structural problem, and why correction can produce benefits that feel disproportionately large relative to the anatomical change being made.
The nasal airway contributes approximately 50 percent of total respiratory resistance during quiet breathing at rest. Significant unilateral nasal obstruction from septal deviation increases total respiratory resistance and shifts the airflow pattern toward mouth breathing at rest, particularly during sleep. Mouth breathing bypasses the nose’s critical humidification, filtration, and warming functions: inspired air enters the lung drier, less filtered, and at ambient temperature rather than the 37°C, near-100-percent-humidity air nasal breathing delivers.
This impairs mucociliary clearance in the lower airways, increases the dry mouth, pharyngeal dryness, and morning sore throat many patients with nasal obstruction experience, and contributes to snoring and sleep-disordered breathing.
The nasal nitric oxide pathway is disrupted by significant nasal obstruction. The paranasal sinuses produce large quantities of nitric oxide (NO) — a molecule with local vasodilatory, antibacterial, and bronchodilatory effects — normally entrained with inspired air and delivered to the lower airways during nasal breathing.
Nasal NO has documented bronchodilatory effects, and chronic mouth breathing from nasal obstruction reduces nasal NO delivery to the lungs, potentially contributing to the increased lower airway reactivity documented in patients with chronic nasal obstruction. This mechanism may partially explain the association between chronic nasal obstruction and asthma, and why treating nasal obstruction (including through septoplasty) often improves asthma control.
Sleep-disordered breathing represents the most clinically consequential functional consequence of significant septal deviation. Upper airway patency during sleep depends on a combination of airway anatomy (including nasal and pharyngeal anatomy), upper airway muscle tone, and the negative pressure developing during inspiration.
Significant nasal obstruction increases the negative inspiratory pressure required to drive airflow through the nose, which transmits to the pharynx and increases the tendency for the pharyngeal wall to collapse — the fundamental mechanism of obstructive sleep apnea. Multiple studies have found nasal obstruction from septal deviation associated with snoring, increased apnea-hypopnea index, and reduced CPAP tolerance.
Septoplasty in patients with OSA and significant nasal obstruction consistently reduces snoring, improves CPAP tolerance and adherence, and in some studies reduces apnea-hypopnea index — though septoplasty alone is generally insufficient to “cure” OSA in patients with significant tongue-base or palatal level obstruction.
Nasal Valve Dysfunction: The Critical Narrowing
Dysfunction of either valve — narrowing from anatomical factors or dynamic collapse during inspiration — produces nasal obstruction that may be the primary functional problem independent of any septal deviation.
Internal nasal valve stenosis is particularly important because it’s commonly associated with septal deviation: a deviated septum can directly narrow the internal valve angle on the side toward which it deviates. Additionally, previous rhinoplasty (cosmetic nose surgery) can narrow the internal valve through overresection of the upper lateral cartilages or displacement of structural support, producing “over-operated nose” nasal obstruction — a challenging functional problem to correct.
Dynamic internal valve collapse — where the upper lateral cartilage collapses medially during inspiration rather than being maintained open by structural support — produces nasal obstruction worse with exertion and deep breathing that may not be apparent at rest.
The Cottle maneuver — placing a fingertip on the cheek lateral to the alar groove and gently pulling the cheek laterally to open the internal valve — demonstrates whether internal valve dysfunction is contributing to nasal obstruction. Significant improvement in breathing with the Cottle maneuver suggests internal valve compromise and indicates that septoplasty alone (which straightens the septum but doesn’t address the lateral cartilage) may be insufficient.
Spreader grafts — cartilage grafts placed between the upper lateral cartilages and the dorsal septum — widen the internal valve and are the standard surgical correction for internal valve stenosis, either performed at the time of septoplasty or as part of functional rhinoplasty.
Evaluation: What the Assessment Should Include
Evaluating suspected symptomatic septal deviation requires more than simple visual inspection or anterior rhinoscopy (using a speculum and headlight to look just inside the nostril).
A complete assessment includes: history (nasal obstruction characteristics including unilaterality, dynamic versus static, exertional variation; associated symptoms including snoring, sleep quality, headache pattern, olfactory changes); external nose examination (assessing the caudal septum, columella, and tip for visible structural deviation); anterior rhinoscopy (assessing the anterior septum and inferior turbinates); and nasal endoscopy with a rigid or flexible endoscope.
Nasal endoscopy — the standard in any rhinological evaluation — allows direct visualization of the entire nasal cavity including the middle and posterior septum, the middle meatus and ostiomeatal complex, the posterior choana, and the nasopharynx.
In the context of suspected septal deviation, endoscopy characterizes the extent and nature of the deviation, identifies spurs (particularly at the septum-vomer junction), assesses turbinate size and any contact with the septum, and excludes concurrent pathology (polyps, mass lesions) that could contribute to symptoms or change management.
Validated patient-reported outcome instruments — the NOSE scale (Nasal Obstruction Symptom Evaluation) for nasal obstruction severity and the SNOT-22 for overall sinonasal quality of life — quantify symptom burden and provide objective tracking of surgical outcomes. Rhinomanometry (measurement of nasal airflow and pressure resistance) and acoustic rhinometry (ultrasound-based measurement of nasal cavity dimensions) provide objective physiological characterization of the obstruction that complements the subjective symptom assessment.
CT imaging of the sinuses is indicated when concurrent sinonasal disease (chronic sinusitis, polyps) is suspected or when surgical planning requires detailed anatomical characterization.
Septoplasty: The Surgery, Its Outcomes, and Its Limitations
Septoplasty — surgical straightening of the deviated nasal septum — is one of the most commonly performed operations in otolaryngology. The technique involves making an incision in the nasal mucosa, elevating the mucosal flaps off the underlying cartilage and bone, removing or repositioning the deviated cartilage and bone causing obstruction, and replacing the mucosal flaps.
The goal is straightening the load-bearing portions of the septum while preserving the cartilage needed for structural support of the nasal tip and dorsum. It’s typically performed under general anesthesia as a day-case procedure, with recovery involving 1–2 weeks of nasal congestion and crusting while the mucosa heals.
The outcomes of septoplasty for symptomatic septal deviation are generally favorable. A 2015 systematic review in Rhinology found septoplasty produces significant improvements in nasal obstruction symptoms, quality of life, and objective airflow measurements in carefully selected patients with symptomatic deviation. Patient satisfaction rates in well-selected populations exceed 80 percent for significant symptom improvement.
The critical determinant of good outcomes is appropriate patient selection: the strongest predictor of surgical success is a clear correlation between the anatomical deviation and the patient’s symptomatic pattern — unilateral obstruction on the same side as the deviation, without other major contributors to obstruction.
The limitations of septoplasty matter equally. Septoplasty straightens the septum — it doesn’t inherently improve all nasal obstruction or eliminate all nasal symptoms. Concurrent inferior turbinate hypertrophy, if not addressed at the same time (through turbinate reduction — submucous resection or outfracture), may leave the patient with persistent obstruction on the contralateral side. Internal nasal valve dysfunction not caused by the septum requires additional surgical correction (spreader grafts, spreader flap techniques).
Chronic rhinosinusitis or nasal polyps contributing to congestion require their own management, and septoplasty doesn’t treat mucosal inflammatory disease. The most common reason for patient dissatisfaction after septoplasty is an inadequate preoperative assessment that failed to identify all contributors to obstruction, leading to a technically successful procedure that provided less relief than expected because the non-septal components went unaddressed.
Non-Surgical Management and When Surgery Is Right
Intranasal corticosteroids reduce mucosal edema and inflammatory contribution to nasal obstruction — they address the mucosal component but can’t change the structural (cartilaginous and bony) deviation. In patients with mild to moderate deviation where much of the obstruction comes from concurrent mucosal swelling (allergic rhinitis, non-allergic rhinitis, or CRS), intranasal corticosteroids can achieve substantial symptom improvement without surgery.
In patients with severe structural deviation where the anatomical problem is the primary obstruction, corticosteroids have limited impact on the fundamental narrowing.
Nasal dilator strips (Breathe Right-type strips, or internal nasal dilators like Mute) mechanically widen the external nasal valve and alar region, improving airflow for some patients — particularly those with dynamic alar collapse and predominantly external valve dysfunction. They don’t address internal valve or septal issues but can be diagnostically useful: a dilator strip dramatically improving breathing suggests external valve dysfunction as a significant component and influences surgical planning.
The surgical timing decision balances the severity of symptoms and their impact on quality of life against the risks of surgery (low but not zero — bleeding, infection, perforation of the septum, saddle nose deformity from over-resection, and persistence or recurrence of symptoms are all possible).
Adults who have tried appropriate non-surgical management for at least three to six months without adequate relief, who have clearly documented symptomatic deviation on endoscopy, and who understand both the potential benefits and the limitations of septoplasty are appropriate surgical candidates. Children and adolescents require more conservative criteria because the septum is still developing — operating on a growing septum carries risk of disturbing nasal growth.
Septoplasty in children is generally deferred until late adolescence (16–18 years) unless severe obstruction creates urgent clinical need.
Common Questions About Deviated Septum
How do I know if my symptoms are from a deviated septum?
The characteristic symptom pattern of clinically significant septal deviation is persistent nasal obstruction, often predominantly on one side, worse with the nasal cycle (the normal alternating congestion between the two nasal chambers that all people experience, which amplifies the asymmetry from the deviated septum), and worse lying on the side toward which the septum deviates. Associated snoring, sleep disruption, mouth breathing, and chronic dry mouth are common.
The diagnosis requires nasal endoscopy to document the deviation and characterize the degree of obstruction — symptoms alone aren’t sufficient because nasal obstruction has many causes that require different management.
Will septoplasty change the shape of my nose?
Standard septoplasty — performed through internal incisions only, addressing the cartilage and bone inside the nose without changing external structural cartilages — typically doesn’t significantly change the external appearance of the nose. Some subtle changes in nasal tip projection or rotation can occur with caudal septum repositioning, but major cosmetic changes don’t result from isolated septoplasty.
When septoplasty combines with rhinoplasty (cosmetic nasal reshaping) — a combined procedure called septorhinoplasty — significant external shape change is intended and achievable. Patients with both structural (deviation) and cosmetic concerns can have both addressed in a single procedure under one anesthetic.
Can a deviated septum cause sleep apnea?
Septal deviation can contribute to sleep apnea by increasing nasal airway resistance, which increases the negative inspiratory pressure transmitted to the pharynx and predisposes to pharyngeal collapse during sleep. However, in most patients with OSA, the pharyngeal anatomy (tongue base, soft palate, lateral pharyngeal walls) is the primary driver of obstruction during sleep, and nasal deviation is a contributing rather than a sufficient cause.
Septoplasty alone is generally insufficient to treat moderate-to-severe OSA, but it consistently improves CPAP tolerance and adherence in patients who require CPAP but struggle with nasal airflow, and it reduces snoring and mild OSA where nasal obstruction is the predominant contributor.
Is septoplasty permanent, or can the deviation come back?
Septoplasty produces permanent anatomical correction in the large majority of patients — cartilage that’s been repositioned and bone that’s been removed or straightened doesn’t “return” to its original position.
However, several factors can produce a perceived recurrence: scar tissue formation in the healing nasal mucosa can gradually narrow the nasal airway over months to years; hypertrophy of the inferior turbinate on the previously “better” side (if it wasn’t hypertrophied at surgery time and wasn’t addressed) may gradually reduce airflow; and new mucosal inflammatory disease (allergic rhinitis, CRS developing after surgery) can add to the obstruction independently of the structural correction.
What is the difference between septoplasty and rhinoplasty?
Septoplasty is a functional procedure that straightens the internal nasal septum to improve nasal airflow. Performed through internal incisions only, it doesn’t significantly change the external appearance of the nose. Rhinoplasty is a cosmetic procedure that reshapes the external nose — the bridge, tip, nostrils, and overall proportions — for aesthetic reasons. Septorhinoplasty combines both: a functional septoplasty to correct internal structural deviation with a cosmetic rhinoplasty to reshape the external nose.
Many patients have both structural and cosmetic concerns, and performing both procedures simultaneously is surgically efficient and allows comprehensive correction. Insurance typically covers the septoplasty component (for documented functional impairment) but not the cosmetic rhinoplasty component in systems with private or public insurance.
Turbinate Hypertrophy: The Septal Deviation’s Partner
Inferior turbinate hypertrophy — persistent or intermittent swelling of the inferior turbinate contributing to nasal obstruction — ranks among the most common anatomical contributors to nasal congestion, both independently and in combination with septal deviation. Understanding turbinate hypertrophy as distinct from but frequently related to septal deviation matters because optimal surgical management of nasal obstruction often requires addressing both rather than treating one in isolation.
The inferior turbinate is a bony structure (the inferior turbinate bone, or inferior concha) covered by a thick layer of highly vascular and glandular mucosa — among the most metabolically active tissues in the upper airway. The turbinate’s fundamental function is air conditioning — the rich vascular plexus warms inspired air to body temperature and humidifies it to near-100-percent relative humidity as it passes through the nasal airway.
The mucosa is supplied by the nasal cycle — the alternating sympathetic and parasympathetic control that causes one turbinate to become more engorged (higher blood flow, more mucosa volume) while the other contracts, then switches. This normal cycle means even people without turbinate pathology have alternating asymmetric nasal airflow throughout the day.
Pathological turbinate hypertrophy — persistent enlargement significantly reducing nasal airway cross-sectional area — occurs through two main mechanisms. Soft tissue (mucosal) hypertrophy involves hyperplasia of the mucosal glandular tissue, submucosal connective tissue, and vascular plexus — the soft tissue component of the turbinate becomes permanently enlarged. Bony hypertrophy involves actual enlargement of the underlying turbinate bone — the bony scroll increases in size, reducing the nasal airway regardless of mucosal state.
Distinguishing soft tissue from bony hypertrophy matters for surgical planning: soft tissue hypertrophy responds to submucous resection and radiofrequency ablation; bony hypertrophy requires outfracture (infracture) of the turbinate bone or partial turbinectomy to address the structural component.
Turbinate reduction at the time of septoplasty — when inferior turbinate hypertrophy is also contributing to obstruction — produces significantly better outcomes than septoplasty alone. A 2016 Cochrane review found combined septoplasty and turbinate reduction produced better nasal airway outcomes than septoplasty alone in patients with both conditions.
The specific turbinate reduction technique (submucous resection, radiofrequency ablation, outfracture, laser reduction) has less impact on outcomes than whether turbinate reduction happens at all — all evidence-based techniques produce comparable symptom improvement when correctly applied.
Postoperative Care and Expectations After Septoplasty
Internal nasal splints or packing (when used) are typically removed at one week, often providing immediate relief as the airway opens.
Postoperative nasal saline irrigation — beginning 24–48 hours after surgery once packing or splints are in place — dramatically improves recovery by clearing blood clots and crusts, maintaining mucosal moisture, and reducing the risk of synechia (adhesion formation between the septum and turbinates that can restrict airflow). Most otolaryngologists prescribe a postoperative intranasal corticosteroid after septoplasty to reduce mucosal inflammation during healing and reduce synechia risk.
Avoiding nose blowing, strenuous exertion, and any activity that might raise nasal blood pressure (bending forward, lifting heavy objects) for the first two weeks reduces the risk of postoperative hemorrhage.
The timeline for maximal benefit from septoplasty is longer than most patients anticipate. The most dramatic improvement in nasal airflow is typically apparent by 4–6 weeks, but the full benefit — particularly improvements in smell and sleep quality resulting from the improved airway — may take 3–6 months to fully manifest as mucosal healing completes and the upper airway adapts to the new anatomy.
Patients reporting “the surgery didn’t work” at two weeks are assessing too early.
The appropriate time to evaluate outcomes is at 3–6 months, once healing is complete and any concurrent medical management for mucosal inflammatory disease has had time to take effect.
Nasal Breathing Physiology: Why It Matters Beyond the Obvious
The debate between nasal versus mouth breathing has expanded far beyond the simple ENT framing of “nasal is good, mouth is necessary when the nose is obstructed.” Research in recent decades has identified nasal breathing advantages operating through mechanisms well beyond air conditioning — including nitric oxide physiology, respiratory pattern regulation, and oral-facial development — that make the restoration of nasal airway patency through septoplasty relevant to health dimensions patients and clinicians rarely discuss.
Nasal nitric oxide — produced in the paranasal sinuses and nasal mucosa in concentrations 100-fold higher than in the lower airways — is entrained with inspired nasal airflow and delivered to the lungs during nasal breathing. Nitric oxide in the lungs acts as a vasodilator of the pulmonary microvasculature, improving ventilation-perfusion matching and increasing oxygen saturation. This mechanism has been specifically demonstrated: nasal breathing measurably increases arterial oxygen saturation compared to mouth breathing at equivalent respiratory rates and volumes.
The nitric oxide also has antiviral and antibacterial properties, with demonstrated in vitro effects against rhinovirus and coronavirus, providing a mechanism by which nasal breathing offers infection defense that mouth breathing bypasses.
Respiratory pattern and blood CO2 regulation are also affected by nasal versus mouth breathing. The nasal airway resistance — approximately 50 percent of total respiratory resistance — provides a physiological load that regulates breath rate and tidal volume. Mouth breathing reduces this resistance, allowing faster and shallower breathing patterns that can produce mild chronic hyperventilation with slightly reduced arterial CO2.
Slightly reduced CO2 shifts the oxyhemoglobin dissociation curve (Bohr effect), reducing oxygen release from hemoglobin to tissues at the same arterial oxygen saturation. The cumulative physiological consequence of chronic mouth breathing — reduced tissue oxygen delivery through the Bohr effect — is an interesting mechanistic pathway between nasal obstruction and systemic symptoms that remains underinvestigated in clinical research but carries theoretical importance.
Orofacial development in children is significantly influenced by nasal versus mouth breathing patterns. Chronic mouth breathing in children — from nasal obstruction due to adenoid hypertrophy, septal deviation, turbinate hypertrophy, or allergic rhinitis — produces a characteristic “adenoid facies” pattern of facial development: long, narrow face; high-arched palate; retrognathic mandible; open-mouth posture; and dental malocclusion.
The mechanism involves the tongue’s position during swallowing and resting: nasal breathers rest the tongue against the palate during swallowing (tongue pushing against and modeling the palate, promoting transverse palatal expansion), while mouth breathers rest the tongue on the floor of the mouth, removing this expansion force and allowing the palate to narrow under the inward pressure of the buccinator muscles.
The palatal narrowing worsens nasal airway resistance by reducing the volume of the nasal cavity (the floor of the nose is the roof of the mouth). Treating nasal obstruction in children early — before the facial skeleton has completed development — can allow more normal facial growth and potentially avoid or reduce the need for orthodontic or orthopedic treatment later.
Rhinitis Medicamentosa: The Decongestant Trap
One of the most common clinical problems encountered in patients with chronic nasal obstruction — including those with septal deviation — is rhinitis medicamentosa (RM): rebound nasal congestion caused by overuse of topical decongestant nasal sprays. This condition is simultaneously ubiquitous (affecting millions of people who use over-the-counter nasal decongestants longer than recommended), poorly understood by the patients experiencing it, and completely preventable with patient education.
Topical decongestants — oxymetazoline (Afrin) and xylometazoline are the most common — are alpha-adrenergic agonists that constrict the nasal mucosal blood vessels, reducing the vascular engorgement contributing to nasal swelling and providing dramatic, rapid relief of nasal congestion. They work quickly and effectively for acute nasal obstruction — viral rhinitis, acute allergic reaction, nasal congestion before air travel.
The problem is their use triggers compensatory upregulation of the adrenergic receptor system: prolonged alpha-adrenergic stimulation leads to receptor downregulation, and when the decongestant effect wears off, the rebound vasodilation is more severe than the original congestion. The patient sprays again to relieve the rebound, further stimulating the compensatory response, and the cycle self-perpetuates.
Patients with rhinitis medicamentosa often don’t realize they’re in this cycle — they experience persistent nasal congestion requiring regular decongestant use and attribute it to their underlying condition (allergy, deviated septum, perpetual sinus infection) rather than to the medication itself. Careful history-taking — specifically asking about frequency and duration of decongestant spray use — reveals the diagnosis.
Treatment requires stopping the topical decongestant and managing the expected rebound congestion with intranasal corticosteroids (which don’t cause rebound), oral antihistamines or decongestants for short-term relief, and saline irrigation. The withdrawal period of 1–2 weeks during which congestion may be severe is the main barrier to successful treatment; tapering by alternating one nostril and then the other (treating one side at a time while the other recovers) can make the process more tolerable.
The relevance to deviated septum management: rhinitis medicamentosa frequently complicates the presentation of patients with septal deviation. A patient with significant septal deviation who develops rhinitis medicamentosa from attempting to manage their obstruction with decongestant sprays has layered a drug-induced problem on top of their structural problem. Septoplasty in the presence of active RM may not produce the expected improvement, because the RM-driven congestion continues after surgery.
Identifying and treating rhinitis medicamentosa before proceeding with surgical management is essential for accurate preoperative symptom assessment and for optimal surgical outcomes.
The Aging Nose and Structural Changes Over Time
The nose and nasal airway undergo predictable structural changes with aging that increasingly contribute to nasal obstruction in older adults, often independently of or in addition to septal deviation. Understanding these age-related changes matters for managing nasal obstruction in older patients and for setting appropriate expectations for surgical intervention.
The nasal tip descends with aging — the paired lower lateral cartilages that support the nasal tip lose their structural support as their connection to the skin thins and as soft tissue changes occur. The “plunging nasal tip” of older age reduces the nasal vestibular area (the airway just inside the nostril) and narrows the external nasal valve, contributing to nasal airflow reduction.
The upper lateral cartilages become more lax with age, reducing internal nasal valve support and increasing the tendency for dynamic internal valve collapse during inspiration. These structural changes reduce nasal airflow even without septal deviation.
The nasal mucosal changes of aging compound the structural changes.
Atrophic rhinitis — characterized by progressive thinning of the nasal mucosa, reduction in goblet cells, impaired mucociliary function, and crusting — is more common with aging and causes paradoxical symptoms: the nasal airway may actually be wider than average (from mucosal atrophy) but patients experience the sensation of nasal obstruction because mucociliary dysfunction impairs the normal sense of nasal airflow, which depends partly on the cooling and stimulating effects of air passing over the mucosal surface.
This “empty nose” sensation — the paradox of a patent airway with severe nasal obstruction symptoms — is one of the most challenging problems in rhinology, both to diagnose correctly and to manage effectively.
Surgical planning in older patients with septal deviation must account for age-related structural changes alongside the deviated septum. Correcting a deviation in an older patient while ignoring the concurrent tip ptosis and internal valve laxity contributing to obstruction produces less complete relief than a comprehensive approach.
Functional rhinoplasty techniques — tip refinement, alar cartilage repositioning, spreader grafts for valve support — combined with septoplasty provide better functional outcomes in appropriately selected older patients than septoplasty alone, and represent the rhinological application of a broader principle: addressing all contributors to a problem produces better results than fixing only the most obvious one.
References
Editorial StandardsCorrectionsMedical DisclaimerAbout Our ContentAffiliate DisclosureSite Map